Editor: NOEL GONZÁLEZ GOTERA Número 184 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 180415 -240415 Foto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba. ARTÍCULOS CIENTÍFICOS Publicaciones incluidas en PubMED durante el período comprendido entre el 18 y el 24 de abril de 2015. Con “vaccin*” en título: 154 artículos recuperados. Vacunas meningococo (Neisseria meningitidis) 150. MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine. Medini D, Stella M, Wassil J. Vaccine. 2015 Apr 13. pii: S0264-410X(15)00468-5. doi: 10.1016/j.vaccine.2015.04.015. [Epub ahead of print] Review. PMID: 25882169 Free Article Related citations Select item 25882168 Vacunas BCG – ONCO BCG (Mycobacterium bovis) 108. Chest wall granuloma associated with BCG vaccination presenting as hot abscess in an immunocompetent infant. Lee HS, Seo KJ, Kim JJ. J Cardiothorac Surg. 2015 Mar 4;10(1):29. doi: 10.1186/s13019-015-0231-z. PMID: 25887440 Free PMC Article Related citations Select item 25887090 1 137. Gamma-Irradiated Bacille Calmette-Guérin Vaccination Does Not Modulate the Innate Immune Response during Experimental Human Endotoxemia in Adult Males. Hamers LA, Kox M, Arts RJ, Blok B, Leentjens J, Netea MG, Pickkers P. J Immunol Res. 2015;2015:261864. doi: 10.1155/2015/261864. Epub 2015 Mar 26. PMID: 25883989 Free PMC Article Related citations Select item 25883262 Vacunas neumococo (Streptococcus pneumoniae) 4. Genetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development. Abry MF, Kimenyi KM, Osowo FO, Odhiambo WO, Sewe SO, Kulohoma BW. Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print] PMID: 25902300 Related citations Select item 25902195 85. Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings. Ward KF, Trent M, Hull BP, Quinn HE, Dey A, Menzies RI. BMC Health Serv Res. 2015 Mar 18;15(1):109. doi: 10.1186/s12913-015-0738-y. PMID: 25889782 Free PMC Article Related citations Select item 25889682 101. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV- infected individuals naive to pneumococcal vaccination. Bhorat AE, Madhi SA, Laudat F, Sundaraiyer V, Gurtman A, Jansen KU, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. AIDS. 2015 Apr 17. [Epub ahead of print] PMID: 25888646 Related citations Select item 25888637 2 104. Prevalence of pilus genes in pneumococci isolated from healthy preschool children in Iceland: association with vaccine serotypes and antibiotic resistance. Hjálmarsdóttir MÁ, Pétursdóttir B, Erlendsdóttir H, Haraldsson G, Kristinsson KG. J Antimicrob Chemother. 2015 Apr 17. pii: dkv096. [Epub ahead of print] PMID: 25888572 Related citations Select item 25888530 112. Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada. Deceuninck G, De Serres G, Boulianne N, Lefebvre B, De Wals P. Vaccine. 2015 Apr 14. pii: S0264-410X(15)00458-2. doi: 10.1016/j.vaccine.2015.04.005. [Epub ahead of print] PMID: 25887086 Related citations Select item 25887084 119. Efficacy of the 7-Valent Pneumococcal Conjugate Vaccine Against Acute Otitis Media Caused by Serotype 6C Pneumococcus. Palmu AA, Kaijalainen T, Jokinen J, Kilpi TM. Pediatr Infect Dis J. 2015 Apr 16. [Epub ahead of print] PMID: 25886787 Related citations Select item 25886704 123. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany. Imöhl M, Möller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O. BMC Infect Dis. 2015 Feb 14;15(1):61. doi: 10.1186/s12879-015-0787-1. PMID: 25885764 Free PMC Article Related citations Select item 25885641 3 Vacunas fiebre tifoidea (Salmonella typhi) 2. Live attenuated vaccines for invasive Salmonella infections. Tennant SM, Levine MM. Vaccine. 2015 Apr 19. pii: S0264-410X(15)00482-X. doi: 10.1016/j.vaccine.2015.04.029. [Epub ahead of print] PMID: 25902362 Related citations Select item 25902360 3. Typhoid fever vaccination strategies. Date KA, Bentsi-Enchill A, Marks F, Fox K. Vaccine. 2015 Apr 19. pii: S0264-410X(15)00481-8. doi: 10.1016/j.vaccine.2015.04.028. [Epub ahead of print] PMID: 25902360 Related citations Select item 25902300 Vacuna tuberculosis (Mycobacterium tuberculosis) 149. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. Schrager L; Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group. Vaccine. 2015 Apr 13. pii: S0264-410X(15)00366-7. doi: 10.1016/j.vaccine.2015.03.056. [Epub ahead of print] PMID: 25882170 Related citations Select item 25882169 Vacunas, otras 1. Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium. Standaert B, Alwan A, Strens D, Raes M, Postma MJ. Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print] No abstract available. PMID: 4 25902371 Related citations Select item 25902362 2. Live attenuated vaccines for invasive Salmonella infections. Tennant SM, Levine MM. Vaccine. 2015 Apr 19. pii: S0264-410X(15)00482-X. doi: 10.1016/j.vaccine.2015.04.029. [Epub ahead of print] PMID: 25902362 Related citations Select item 25902360 3. Typhoid fever vaccination strategies. Date KA, Bentsi-Enchill A, Marks F, Fox K. Vaccine. 2015 Apr 19. pii: S0264-410X(15)00481-8. doi: 10.1016/j.vaccine.2015.04.028. [Epub ahead of print] PMID: 25902360 Related citations Select item 25902300 4. Genetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development. Abry MF, Kimenyi KM, Osowo FO, Odhiambo WO, Sewe SO, Kulohoma BW. Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print] PMID: 25902300 Related citations Select item 25902195 5. Sycosis Vaccinatum, a Type of Vaccinia Folliculitis. 5 Braswell MA, Morrissey MW, Ritchie SA, Reddick RL, Kobayashi TT. JAMA Dermatol. 2015 Apr 22. doi: 10.1001/jamadermatol.2015.0380. [Epub ahead of print] No abstract available. PMID: 25902195 Related citations Select item 25902103 6. [Optic Neuritis after Influenza Vaccination in a Patient after Stem Cell Transplantation]. Jöhr N, Tschopp M, Hollbach N, Gerull S, Halter J, Klenk L, Goldblum D. Klin Monbl Augenheilkd. 2015 Apr;232(4):484-486. Epub 2015 Apr 22. German. No abstract available. PMID: 25902103 Related citations Select item 25901995 7. Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study. Kondo K, Suzuki K, Washio M, Ohfuji S, Fukushima W, Maeda A, Hirota Y. Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print] PMID: 25901995 Related citations Select item 25901962 8. Correction: Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis. Baharia RK, Tandon R, Sharma T, Suthar MK, Das S, Siddiqi MI, Saxena JK, Sundar S, Dube A. PLoS Negl Trop Dis. 2015 Apr 22;9(4):e0003742. doi: 10.1371/journal.pntd.0003742. eCollection 2015 Apr. 6 PMID: 25901962 Related citations Select item 25901737 9. Correction: Rational Development of an Attenuated Recombinant Cyprinid Herpesvirus 3 Vaccine Using Prokaryotic Mutagenesis and In Vivo Bioluminescent Imaging. PLOS Pathogens Staff. PLoS Pathog. 2015 Apr 22;11(4):e1004861. doi: 10.1371/journal.ppat.1004861. eCollection 2015 Apr. PMID: 25901737 Related citations Select item 25901415 10. A vaccine against Ebola: Problems and opportunities. Rezza G. Hum Vaccin Immunother. 2015 Apr 22:0. [Epub ahead of print] PMID: 25901415 Related citations Select item 25901343 11. CMS now publicly reporting hospital flu vaccination rates. [No authors listed] Hosp Peer Rev. 2015 Apr;40(4):44-6. No abstract available. PMID: 25901343 Related citations Select item 25901285 12. Bridging infectious disease vaccines with cancer immunotherapy: a role for targeted RNA based immunotherapeutics. 7 Sayour EJ, Sanchez-Perez L, Flores C, Mitchell DA. J Immunother Cancer. 2015 Apr 21;3:13. doi: 10.1186/s40425-015-0058-0. eCollection 2015. PMID: 25901285 Related citations Select item 25901173 13. Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran. Khatibi M, Rasekh HR. Iran J Pharm Res. 2015 Spring;14(2):635-49. PMID: 25901173 Related citations Select item 25900822 14. Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic. Breitbach CJ, Parato K, Burke J, Hwang TH, Bell JC, Kirn DH. Curr Opin Virol. 2015 Apr 16;13:49-54. doi: 10.1016/j.coviro.2015.03.016. [Epub ahead of print] Review. PMID: 25900822 Related citations Select item 25900771 15. Pediatric orbital cellulitis in the Haemophilus influenzae vaccine era. Sharma A, Liu ES, Le TD, Adatia FA, Buncic JR, Blaser S, Richardson S. J AAPOS. 2015 Apr 18. pii: S1091-8531(15)00088-9. doi: 10.1016/j.jaapos.2015.02.004. [Epub ahead of print] PMID: 25900771 Related citations 8 Select item 25900433 16. Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer. Klosky JL, Russell KM, Simmons JL, Foster RH, Peck K, Green DM, Hudson MM. Pediatr Blood Cancer. 2015 Apr 20. doi: 10.1002/pbc.25539. [Epub ahead of print] PMID: 25900433 Related citations Select item 25900321 17. Deoxynivalenol in chicken feed alters the vaccinal immune response and clinical biochemical serum parameters but not the intestinal and carcass characteristics. Ghareeb K, Awad WA, Zebeli Q, Böhm J. J Anim Physiol Anim Nutr (Berl). 2015 Apr 21. doi: 10.1111/jpn.12328. [Epub ahead of print] PMID: 25900321 Related citations Select item 25900134 18. The Benin experience: How computational modeling can lead to major vaccine policy changes in low and middle income countries. Lee BY, Schreiber B, Wateska AR, Connor DL, Dicko HM, Jaillard P, Mvundura M, Levin C, Avella M, Haidari LA, Brown ST. Vaccine. 2015 Apr 18. pii: S0264-410X(15)00475-2.